Home / Research Library / VENTANA MEDICAL SYSTEMS INC. Received a Patent for ENHANCED DEPOSITION OF CHROMOGENS UTILIZING PYRIMIDINE ANAL
GIPResearch.com · Patent and Technology Research
VENTANA MEDICAL SYSTEMS INC. Received a Patent for ENHANCED DEPOSITION OF CHROMOGENS UTILIZING PYRIMIDINE ANALOGS
Ventana Medical Systems, Inc. develops, manufactures, and markets instrument reagent systems. The Company offers medical products to automate tissues and slide staining. In India, the Pharmaceutical business of Ventana Medical Systems, Inc. is focused on Automated coverslipper and methods of use,…
VENTANA MEDICAL SYSTEMS INC. Received a Patent for ENHANCED DEPOSITION OF CHROMOGENS UTILIZING PYRIMIDINE ANALOGS — research background
Research context: This article preserves existing publication material for continuity. Technical, commercial and legal references should be checked against current primary sources before making decisions.
Ventana Medical Systems, Inc. develops, manufactures, and markets instrument reagent systems. The Company offers medical products to automate tissues and slide staining.
In India, the Pharmaceutical business of Ventana Medical Systems, Inc. is focused on Automated coverslipper and methods of use, Method and apparatus for imaging a sample using a microscope scanner, Method and apparatus for imaging a sample using a microscope scanner,Automated high volume slide processing system.
Ventana Medical Systems, Inc. filed patent application numbered 4502/DELNP/2013 that is titled ENHANCED DEPOSITION OF CHROMOGENS UTILIZING PYRIMIDINE ANALOGS. This patent application has been granted as Patent Number 316900.
The invention covers Microbiology compounds. This invention relates to compositions that enhance the deposition of detectable moieties on tissue samples, methods utilizing these compositions and kits including these compositions. The compositions include a deposition enhancer having a formula and/or where R1, R2, R3, and R4 are independently selected from aliphatic, aryl, halogen, a heteroatom-containing moiety, and hydrogen; R1 and/or R3 can be bound to R2 to form a fused, aromatic ring system; R5 is selected from a heteroatom-containing moiety; A is selected from, a carbon atom, a heteroatom, other than sulfur, and any combination thereof; n is 1-5, an enzyme, a specific binding moiety and a detectable moiety.
During patent examination, the patent examiner raised objections under Section 3(d) of the Indian Patents Act, wherein the examiner stated that the Claims 1-19 falls under section 3(d) of Patent Act 1970, as it is directed to mere use of a known method for detecting a target in a sample by proximally depositing a marker. In the absence of experiment data, it is unclear whether any unknown technical effect is produced or not.
As a response to said objection, the applicant made submissions to have been reiterated and it has been made to look at them again as it is a novel method.
Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.
Discuss a research question related to VENTANA MEDICAL SYSTEMS INC. Received a Patent
Describe your objective and the evidence you need. The suitability and scope of any research engagement will be confirmed individually.
Source and context: Original GIPResearch.com publication dated 2019-09-12. Existing text is retained for historical continuity. Verify time-sensitive matters using official records.